[1] Chen W,Zheng R,Zhang S,et al. Annual report on status of cancer in China[J]. Chin J Cancer Res,2014,26(1):48-58.
[2] Takai E,Yano T,Iguchi H,et al. Tumor-induced hypercalcemia and parathyroid hormone-related protein in lung carcinoma[J]. Cancer,1996,78(7):1384-1387.
[3] Santarpia L,Koch C A,Sarlis N J.Hypercalcemia in cancer patients: pathobiology and management[J]. Horm Metab Res,2010,42(3):153-164.
[4] Bae H M,Lee S H,Kim T M,et al.Prognostic factors for nonsmall cell lung cancer with bone metastasis at the time of diagnosis [J].Lung cancer,2012,77(3):572-577.
[5] 唐 顺,郭 卫,杨荣利.127例肺癌骨转移患者随访的预后因素分析[J].中国肿瘤临床,2008,35(23):1335-1338.
[6] Grunnet M,Sorensen J B. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer[J]. Lung Cancer,2012,76(2):138-143.
[7] 朱自力,朱海霞,张福明,等.肺癌患者血清肿瘤标志物水平与骨转移的关系[J]. 江苏医药,2011,37(8):943-945.
[8] Shi Y,Au J S,Thongprasert S,et al.A prospective,molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)[J].J Thorac Oncol,2014,9(2):154-162.
[9] 王海英,周孟强,臧 凯.血钙水平测定对诊断肺癌骨转移的临床意义[J]. 肿瘤基础与临床,2012,25(5):422-423.